Person Centered Nursing Homes: Impact Assessment Of Centered Person Care In Nursing Homes

• Conditions: Mood; Health Services for the Aged; Quality of Life
• Interventions: Other: ACP intervention

• Registration Number: NCT03200145
• Lead Sponsor: Fundacio Salut i Envelliment UAB

Brief Summary

Cohort Observational Study. The study will assess differences in quality of life, well-being and mood between persons living in a nursing home following usual care and persons living in nursing homes following a centered person care model.

Initially, the follow up will last 6 months, with the possibility to be extended.

Detailed Description

Not available

Study Timeline

• Status Verified: 2017-06
• Study First Submitted: 2017-06-20
• Study First Submitted QC: 2017-06-26
• Last Update Submitted: 2017-06-26
• Study Start: 2017-06-27
• Study First Posted: 2017-06-27
• Last Update Posted: 2017-06-27
• Primary Completion: 2018-02
• Study Completion: 2018-02

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 170

Inclusion Criteria

• Persons living in nursing homes
• Consent from the person (or legal representative, if the person is not able)

Exclusion Criteria

• Terminal illness
• Living temporary in a nursing home

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Control	ACP intervention	The control group is made by persons living in nursing homes under usual care

Primary Outcome Measures

Name	Time	Method
Thriving in nursing homes	0, 6 months	Thriving in nursing homes will be assessed with the Thriving of Older People Assessment Scale (TOPAS).; Investigators will assess the change between groups.
Quality of life	0, 6 months	Quality of life will be assessed with the Euroqol 5D-5L. Investigators will assess the change between groups.
Well-being	0, 6 months	Well-being will be assessed by the WHO (Five) Well Being Index (1998 version). Investigators will assess the change between groups.

Secondary Outcome Measures

Name	Time	Method
Depressive symptoms	0, 6 months	Cognitive impairment affects the assessment of depressive symptoms. For this reason, according to their stage using the Reisberg Global Deterioration Scale, investigators will assess the presence or absence of depressive symptoms with two tools; * stage 0 to 4: investigators will consider that a person has depressive symptoms with a score of 6 or more using the 15 items Yesavage Geriatric Depression Scale,; * stage 5 to 7: investigators will consider that a person has depressive symptoms with a score of 11 or more using the Cornell Depression Scale.; Investigators will assess the change in the prevalence of depressive symptoms between groups.
Neuropsychiatric inventory	0,6 months	Neuropsychiatric symptoms will be assessed with the Brief Neuropsychiatric inventory(NPI-Q). Investigators will assess the change between groups.

Trial Locations

Locations (2)

Residència "Casa del Avis"; 🇪🇸 Sant Sadurní d'Anoia, Barcelona, Spain

Residència i Centre de dia Sant Hilari; 🇪🇸 Sant Hilari Sacalm, Girona, Spain